Calvin Yu

Calvin Yu is the current Vice President of Finance at Alector. Prior to their current position, they served as the Corporate Controller at Stemcentrx, Inc. from February 2016 to June 2017. From September 2014 to February 2016, Calvin was the Senior Director of Finance and SEC Reporting at Adverum Biotechnologies Inc. Calvin also served as the Director of Controller at Five Prime Therapeutics from March 2010 to September 2014 and as the Senior Manager of SOX Compliance and SEC Reporting at Proteolix from May 2009 to March 2010. Calvin's other previous positions include SEC Reporting and Compliance Manager at Cell Genesys from June 2007 to May 2009 and Audit Manager at Ernst & Young from January 2003 to December 2007. Calvin began their career as an Audit Senior at Moss Adams LLP from January 2002 to December 2003.

Calvin Yu graduated from San Francisco State University with a Bachelor of Science in Accounting from the Lam Family College of Business.

Some of their coworkers include Stephanie Yonker - VP of Legal, Robert King - Chief Development Officer, and Hua Long - Senior Director of Pre-clinical Research. Calvin Yu reports to Arnon Rosenthal, CEO.